Topics Covered:
• Features and behaviours unique to the endogenous compound slot
• Considerations for endogenous biomarker outputs, overlays and P.E template
• Provide a brief summary of available endogenous molecule files
Certara accelerates medicines to patients using proprietary biosimulation software and technology to transform traditional drug discovery and development. Its clients include 1,600 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 60 countries.
Please visit us at www.certara.com/